Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1 is an incretin hormone that enhances insulin secretion in response to meals and promotes satiety
This MDL consolidates federal lawsuits filed across the country that allege GLP-1 receptor agonist drugs commonly prescribed for type 2 diabetes and weight loss caused NAION, a condition that damages the optic nerve and can result in sudden, permanent vision loss
No one taking placebo quit the trial early
Severe or persistent diarrhea defined as more than six loose stools daily lasting beyond 48 hoursrequires clinical assessment to prevent complications and rule out alternative causes unrelated to the weight loss medication
Wegovy, conversely, is prescribed for chronic weight management
A 2025 study reported evidence of telomere length stabilization or modest lengthening, raising the possibility that metabolic therapies may influence pathways related to genomic stability and replicative lifespan [16]
US$ 21.43
US$ 28.28
US$ 24.40
US$ 24.97
